Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Eris Lifesciences has completed its acquisition of the Velbiom Probiotics business. The transaction is categorized as an add-on and is marked as closed.
The available deal details do not include purchase price, geography, or the specific product scope of the Velbiom Probiotics business.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026